I agree that this site is using cookies. You can find further informations here.
X
Arhin, Francis F.
89  results:
Search for persons X
?
1

In vitro activity of aztreonam-avibactam and comparators ag..:

Rossolini, Gian Maria ; Arhin, Francis F. ; Kantecki, Michal
Journal of Global Antimicrobial Resistance.  36 (2024)  - p. 123-131 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Antimicrobial Activities of Aztreonam-Avibactam and Compara..:

Piérard, Denis ; Hermsen, Elizabeth D. ; Kantecki, Michal.
Antibiotics.  12 (2023)  11 - p. 1591 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Ceftazidime-avibactam activity against Gram-negative respir..:

Kempf, Marie ; Arhin, Francis F. ; Stone, Gregory.
Journal of Global Antimicrobial Resistance.  31 (2022)  - p. 239-247 , 2022
Link: https://doi.org/10.1016/..
 
?
4

In vitro activity of aztreonam/avibactam against isolates o..:

Rossolini, Gian Maria ; Stone, Gregory ; Kantecki, Michal.
Journal of Global Antimicrobial Resistance.  30 (2022)  - p. 214-221 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Investigation of mechanisms responsible for decreased susce..:

Mendes, Rodrigo E ; Doyle, Timothy B ; Streit, Jennifer M...
Journal of Antimicrobial Chemotherapy.  76 (2021)  11 - p. 2833-2838 , 2021
Link: https://doi.org/10.1093/..
 
?
6

Molecular characterization of clinical isolates of Enteroba..:

Estabrook, Mark ; Kazmierczak, Krystyna M. ; Wise, Mark...
Journal of Global Antimicrobial Resistance.  24 (2021)  - p. 316-320 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Agar dilution minimum inhibitory concentrations under-repre..:

Arhin, Francis F. ; Moeck, Gregory
Journal of Global Antimicrobial Resistance.  9 (2017)  - p. 85-86 , 2017
Link: https://doi.org/10.1016/..
 
?
8

In vitro stepwise selection of reduced susceptibility to li..:

Arhin, Francis F. ; Seguin, David Lalonde ; Belley, Adam.
Diagnostic Microbiology and Infectious Disease.  89 (2017)  2 - p. 168-171 , 2017
Link: https://doi.org/10.1016/..
 
?
9

In vitro activity of Oritavancin against gram-positive path..:

Karlowsky, James A. ; Walkty, Andrew J. ; Baxter, Melanie R....
Diagnostic Microbiology and Infectious Disease.  87 (2017)  4 - p. 349-356 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Assessment of the potential for oritavancin MIC changes amo..:

Arhin, Francis F. ; Moeck, Gregory
Journal of Global Antimicrobial Resistance.  9 (2017)  - p. 8-9 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Comparative in vitro activity of oritavancin and other agen..:

Sweeney, Debora ; Shinabarger, Dean L. ; Arhin, Francis F....
Diagnostic Microbiology and Infectious Disease.  87 (2017)  2 - p. 121-128 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Comparativein vitroactivity of oritavancin and other agents..:

Sweeney, Debora ; Stoneburner, Audrey ; Shinabarger, Dean L....
Journal of Antimicrobial Chemotherapy.  72 (2016)  2 - p. 622-624 , 2016
Link: https://doi.org/10.1093/..
 
?
13

Pooled analysis of single-dose oritavancin in the treatment..:

Corey, G. Ralph ; Arhin, Francis F. ; Wikler, Matthew A....
International Journal of Antimicrobial Agents.  48 (2016)  5 - p. 528-534 , 2016
Link: https://doi.org/10.1016/..
 
?
14

In vitro activity of oritavancin and comparator agents agai..:

Biedenbach, Douglas J. ; Arhin, Francis F. ; Moeck, Gregory..
International Journal of Antimicrobial Agents.  46 (2015)  6 - p. 674-681 , 2015
Link: https://doi.org/10.1016/..
 
?
15

In vitro activities of oritavancin and comparators against ..:

Arhin, Francis F. ; Sarmiento, Ingrid ; Moeck, Gregory
International Journal of Antimicrobial Agents.  44 (2014)  1 - p. 65-68 , 2014
Link: https://doi.org/10.1016/..
 
1-15